Cedars Sinai Medical Center - Net Worth and Insider Trading
Cedars Sinai Medical Center Net Worth
The estimated net worth of Cedars Sinai Medical Center is at least $7 Million dollars as of 2024-11-13. Cedars Sinai Medical Center is the 10% Owner of Capricor Therapeutics Inc and owns about 404,996 shares of Capricor Therapeutics Inc (CAPR) stock worth over $7 Million. Details can be seen in Cedars Sinai Medical Center's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cedars Sinai Medical Center has not made any transactions after 2017-05-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cedars Sinai Medical Center
Cedars Sinai Medical Center Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cedars Sinai Medical Center owns 2 companies in total, including Capricor Therapeutics Inc (CAPR) , and Prometheus Biosciences Inc (RXDX) .
Click here to see the complete history of Cedars Sinai Medical Center’s form 4 insider trades.
Insider Ownership Summary of Cedars Sinai Medical Center
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2017-05-09 | 10 percent owner |
| RXDX | Prometheus Biosciences Inc | 2021-03-11 | 10 percent owner |
Cedars Sinai Medical Center Latest Holdings Summary
Cedars Sinai Medical Center currently owns a total of 1 stock. Cedars Sinai Medical Center owns 404,996 shares of Capricor Therapeutics Inc (CAPR) as of May 9, 2017, with a value of $7 Million.
Latest Holdings of Cedars Sinai Medical Center
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CAPR | Capricor Therapeutics Inc | 2017-05-09 | 404,996 | 18.10 | 7,330,428 |
Holding Weightings of Cedars Sinai Medical Center
Cedars Sinai Medical Center Form 4 Trading Tracker
According to the SEC Form 4 filings, Cedars Sinai Medical Center has made a total of 0 transactions in Capricor Therapeutics Inc (CAPR) over the past 5 years. The most-recent trade in Capricor Therapeutics Inc is the acquisition of 114,516 shares on May 9, 2017, which cost Cedars Sinai Medical Center around $4 Million.
Insider Trading History of Cedars Sinai Medical Center
- 1
Cedars Sinai Medical Center Trading Performance
GuruFocus tracks the stock performance after each of Cedars Sinai Medical Center's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cedars Sinai Medical Center is 0.16%. GuruFocus also compares Cedars Sinai Medical Center's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cedars Sinai Medical Center within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cedars Sinai Medical Center's insider trading performs compared to the benchmark.
Performance of Cedars Sinai Medical Center
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.78 | | | | | |
| Relative Return to S&P 500(%) | -19.81 | | | | | |
Cedars Sinai Medical Center Ownership Network
Ownership Network List of Cedars Sinai Medical Center
Ownership Network Relation of Cedars Sinai Medical Center
Cedars Sinai Medical Center Owned Company Details
What does Capricor Therapeutics Inc do?
Who are the key executives at Capricor Therapeutics Inc?
Cedars Sinai Medical Center is the 10 percent owner of Capricor Therapeutics Inc. Other key executives at Capricor Therapeutics Inc include CHIEF BUSINESS OFFICER Xavier Avat , director & CHIEF EXECUTIVE OFFICER Linda Marban , and EVP & GENERAL COUNSEL Karen Krasney .
Capricor Therapeutics Inc (CAPR) Insider Trades Summary
Over the past 18 months, Cedars Sinai Medical Center made no insider transaction in Capricor Therapeutics Inc (CAPR). Other recent insider transactions involving Capricor Therapeutics Inc (CAPR) include a net purchase of 7,993 shares made by David B Musket , a net purchase of 2,798,507 shares made by , and a net purchase of 10,000 shares made by Collier Earl M Jr .
In summary, during the past 3 months, insiders sold 0 shares of Capricor Therapeutics Inc (CAPR) in total and bought 2,798,507 shares, with a net purchase of 2,798,507 shares. During the past 18 months, 0 shares of Capricor Therapeutics Inc (CAPR) were sold and 2,821,500 shares were bought by its insiders, resulting in a net purchase of 2,821,500 shares.
Capricor Therapeutics Inc (CAPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Capricor Therapeutics Inc Insider Transactions
Cedars Sinai Medical Center Mailing Address
Above is the net worth, insider trading, and ownership report for Cedars Sinai Medical Center. You might contact Cedars Sinai Medical Center via mailing address: 8700 Beverly Blvd, Los Angeles Ca 90048-1865.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
